Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

  • Laser treatment shows promise for skin cancer

BioPhotonics
Jun 2014
CAMBRIDGE, Mass., Feb. 7, 2014 — The treatment of basal-cell carcinoma (BCC) with a new combination of lasers – pulsed dye and Nd:YAG – has yielded some good results, offering the potential for nonsurgical treatment.

A research team from Harvard University, which had previous success in treating BCC with a combination of pulsed dye and alexandrite lasers, is studying the effect of repeated treatment of BCC with pulsed dye and Nd:YAG lasers. The investigators treated superficial and nodular subtypes of the disease of varying diameters.


Basal-cell carcinoma tumors, before and after treatment using pulsed dye and Nd:YAG lasers. The top row shows the tumors prior to treatment, while the bottom row shows post-treatment results. Courtesy American Society for Laser Medicine and Surgery.


“In this study, we combined two different wavelengths of light that target blood,” said Dr. H. Ray Jalian. “All cancers, whether they are in the skin or elsewhere, rely on a rich blood supply to support rapid growth of the tumor. Oftentimes these blood vessels are abnormal and different from the surrounding blood vessels in the tissue. If we are able to selectively target them, then we may be able to inhibit growth of tumors.”

As part of this study, 10 subjects with 13 biopsy-proven BCCs received four combined PDL and Nd:YAG treatments at 2- to 4-week intervals. The tumors and 4 mm of peripheral skin were treated using standardized parameters delivered with a 7-mm spot with 10 percent overlap. The treated area was excised and evaluated histologically for residual tumor.

The researchers found that many skin cancers measuring less than 1.5 cm cleared with the series of four treatments.

The study uncovered some potential reasons for treatment failure, including tumor subclassification (superficial basal-cell carcinoma) and the use of blood thinners that could inhibit clot formation after laser treatment.

The team plans to further refine its strategies for laser-based anti-angiogenesis-based treatment of basal-cell carcinoma.

The work is published in Lasers in Surgery and Medicine.

For more information, visit www.aslms.org.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Facebook Google+ LinkedIn Facebook RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!